(R)-3-Amino-4-(3-fluorophenyl)butanoic acid hydrochloride
98%
- Product Code: 81913
CAS:
331763-65-6
| Molecular Weight: | 233.667 g./mol | Molecular Formula: | C₁₀H₁₃ClFNO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD01860912 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, inert gas protection |
Product Description:
This compound is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological and psychiatric disorders. Its structure, featuring a fluorophenyl group and an amino acid moiety, makes it valuable for designing drugs that interact with specific neurotransmitter systems, such as GABA or glutamate receptors. Additionally, it is explored for its potential in creating enantiomerically pure compounds, which are critical for developing therapies with improved efficacy and reduced side effects. Its applications extend to preclinical studies aimed at understanding the mechanisms of action of novel therapeutic agents.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | Ft45,574.48 |
+
-
|
| 0.250 | 10-20 days | Ft68,458.68 |
+
-
|
(R)-3-Amino-4-(3-fluorophenyl)butanoic acid hydrochloride
This compound is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological and psychiatric disorders. Its structure, featuring a fluorophenyl group and an amino acid moiety, makes it valuable for designing drugs that interact with specific neurotransmitter systems, such as GABA or glutamate receptors. Additionally, it is explored for its potential in creating enantiomerically pure compounds, which are critical for developing therapies with improved efficacy and reduced side effects. Its applications extend to preclinical studies aimed at understanding the mechanisms of action of novel therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :